Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Cancer Imaging? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
CI
Cancer Imaging is the official journal of the International Cancer Imaging Society and covers the interdisciplinary field of cancer imaging. It publishes original research, reviews, correspondence, and editorials for radiologists, nuclear medicine specialists, oncologists, oncological surgeons, and related specialists.
Looking to publish in Cancer Imaging? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
Impact Factor
3.5
Quartile
Q2
Open Access Type
Open
ISSN
1740-5025
eISSN
1470-7330
Invitation Only
Yes
Cost Range
£2290.00 GBP / $2890.00 USD / €2490.00 EUR APC; subject to VAT or local taxes where applicable.
Submission Instructions
Cancer Imaging is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Research Article
Cover Letter
A cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare potential competing interests, confirm all authors approved submission, and confirm the content has not been published or submitted elsewhere.
Abstract
An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusions, and for health care intervention studies on human participants must also include a Trial registration section with registration number and date, adding 'retrospectively registered' when applicable.
Manuscript
Main text must not exceed 3,500 words. Manuscript must include Background, Methods, Results, Discussion, Conclusions, and a Declarations section. Manuscript must include three to ten keywords, a Declarations section with the specified subheadings retained even when marked 'Not applicable', a list of abbreviations if abbreviations are used, and documentation of any large language model use in the Methods section or a suitable alternative part of the manuscript.
References
References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and public preprints may be cited, unpublished abstracts/data/personal communications must be excluded from the reference list, web links must be numbered and included in the reference list in full, and journal abbreviations must follow Index Medicus/MEDLINE.
Figures & Tables
Manuscript may include no more than 10 figures with a maximum of 16 figure parts. Figure titles and legends must appear in the main manuscript while figures are uploaded separately, and tables under one page may be placed in the text whereas larger tables may be placed at the end of the document. Figures must be numbered in text order and multi-panel figures submitted as single composite files, while tables must be numbered in sequence and created using the word processor's table function rather than embedded as figures or spreadsheet files.
Review
Cover Letter
A cover letter is required. Cover letter must explain why the manuscript should be published in Cancer Imaging, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, confirm the manuscript has not been published or submitted elsewhere, and name any special issue if applicable.
Abstract
An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include Background, Main body of the abstract, and short Conclusion.
Manuscript
Main text must not exceed 4000 words. Manuscript must include Background, Main text, Conclusions, and a Declarations section. Manuscript must include three to ten keywords and a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, Acknowledgements, and optional Authors' information, using 'Not applicable' where a subsection is not relevant.
References
References must follow Vancouver reference style. Only articles, clinical trial registration records, and abstracts that are published, in press, or publicly available as e-prints or preprints may be cited, and web links or URLs must be numbered and included in the reference list.
Figures & Tables
Reviews may include up to 12 figures with up to 30 figure parts. Tables shorter than one page may be placed within the manuscript, tables longer than one page may be placed at the end of the document, and figure titles and legends must be provided in the main manuscript rather than in the graphic files. Tables must not be embedded as figures or spreadsheet files, and footnotes must be used instead of endnotes with table footnotes indicated by superscript lower-case letters or asterisks for significance values and other statistical data.
Case Series
Cover Letter
A cover letter is required. Cover letter must explain why the manuscript should be published, address any journal policy issues, declare any potential competing interests, confirm all authors approved submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract
An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings 'Background', 'Case presentation', and 'Conclusions'.
Manuscript
Main text must not exceed 2,500 words. Manuscript must include a title page, three to ten keywords, a Background section, a Case presentation section, a Discussion and Conclusions section, and a Declarations section. Declarations section must include the subheadings 'Ethics approval and consent to participate', 'Consent for publication', 'Availability of data and materials', 'Competing interests', 'Funding', 'Authors' contributions', and 'Acknowledgements', with 'Not applicable' used for any subsection that is not relevant, and any use of a Large Language Model must be documented in the Methods section or another suitable part of the manuscript.
References
References must follow Vancouver reference style. Only articles, clinical trial registration records, and abstracts that are published, in press, or publicly available may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web references must be numbered and given in full with site title, URL, and access date.
Figures & Tables
Case Series may include up to 4 figures with a maximum of 10 figure parts. Figure titles and legends must be provided in the main manuscript, tables shorter than one page can be placed within the manuscript, and tables longer than one page can be placed at the end of the document with their intended locations indicated in the text. Figures must be numbered in text order and multi-panel figures submitted as a single composite file, while tables must be numbered in sequence and must not be embedded as figures or spreadsheet files.
Correspondence
Cover Letter
A cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract
An abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured. Abstract must briefly summarize the aim, findings, or purpose of the article and should minimize the use of abbreviations without citing references.
Manuscript
Main text must be within 500–1,000 words. Manuscript must include a title page and a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, with optional Authors' information. Manuscript must provide three to ten keywords and include declarations using 'Not applicable' where a declarations subsection is not relevant, including specified competing interests and author contributions statements.
References
References must not exceed 10. References must follow Vancouver reference style. Only articles, clinical trial registration records, and abstracts that are published, in press, or publicly available as e-prints/preprints may be cited, while unpublished abstracts, unpublished data, and personal communications must not appear in the reference list.
Figures & Tables
A maximum of two figures or two tables, or one figure plus one table, is permitted. Tables less than one page may be placed within the manuscript, tables larger than one page may be placed at the end of the document, and figure titles and legends must be provided in the main manuscript rather than in the graphic file. Figures and tables must be numbered in sequence, and footnotes rather than endnotes must be used, with no figures or tables in text footnotes.
Editorial
Cover Letter
A cover letter is required. The cover letter must explain why the manuscript should be published, address any journal policy issues, declare any potential competing interests, confirm all authors approved the submission, confirm the content is not published or under consideration elsewhere, and name any special issue if applicable.
Abstract
An abstract is required. The abstract should not exceed 250 words. The abstract should be unstructured and briefly summarize the aim, findings, or purpose of the article.
Manuscript
Editorials should be a maximum of 1,000 words. The main text should contain the body of the article and may be divided into short, informative subsections, and the manuscript must include a Declarations section. Editorials must include three to ten keywords, an Availability of data and materials statement, a Declarations section marked 'Not applicable' if irrelevant, a list of abbreviations if abbreviations are used, funding and author contribution statements, and documentation of any Large Language Model use in the Methods section or another suitable section.
References
Editorials may include no more than 10 references. References must follow Vancouver style. If an author or group can clearly be associated with a web link, they should be included in the reference, and web links must be cited in the reference list rather than in the text.
Figures & Tables
Tables shorter than one page may be placed within the manuscript, while longer tables may be placed at the end of the document with callouts in the text, and figure titles and legends must appear in the main manuscript rather than in the graphic files. Figures must be numbered in order and uploaded separately, while tables must be created using the word processor's table function and not embedded as figures.
Recent Publications
[18F] PSMA-3Q PET/CT radiomics at 45% SUVmax threshold: predicting post-surgical ISUP grade ≥ 4 and extraprostatic extension for noninvasive stratification in prostate cancer management
Jianbo Cui, Yachao Liu, Guanyun Wang, Xiaodan Xu, Dong Zhao, Ran Xue, Wenjing Chen, Ruimin Wang, Baixuan Xu
10.1186/s40644-026-01050-8
View Publication
Use of contrast-enhanced mammography for preoperative prediction of lymphovascular invasion status in invasive breast cancer
Liya Gong, Muzi Wen, Ying Ye, Zhiyue Zhao, Junyan Wen, Ziqi Wu, Yanyu Hao, Xiaomei Huang
10.1186/s40644-026-01065-1
View Publication
Long-term prognostic value of 18F-FLT PET/CT versus 18F-FDG PET/CT in locally advanced oesophageal squamous cell carcinoma: a prospective study
Wenyan Gao, Jingwen Peng, Xue Chen, Yi Wang, Shunji Zhi, Lei Wu, Gang Wan, Zhuzhong Cheng, Qifeng Wang, Wei Zhang
10.1186/s40644-026-01056-2
View Publication
Prognostic value of 18F-FDG PET/CT metabolic parameters in patients with non–small cell lung cancer who achieved a pathological complete response after neoadjuvant chemoimmunotherapy
Ye Tao, Rui Guo, Xiang Li, Xinrun Cui, Yaqi Wang, Haoxuan Du, Zengjin Wen, Shi Yan, Nan Li, Nan Wu
10.1186/s40644-026-01057-1
View Publication
Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastases
Mihaela Rata, Khurum Khan, David J. Collins, Matthew R. Orton, James d’Arcy, Nina Tunariu, Maria Antonietta Bali, Ian Chau, Nicola Valeri, David Cunningham, Dow-Mu Koh
10.1186/s40644-026-01063-3
View Publication
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 8 days.
Reformat to Cancer Imaging using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should explain why the manuscript should be published in Cancer Imaging, address any issues relating to journal policies, declare potential competing interests, confirm all authors have approved the submission, confirm the manuscript has not been published or submitted elsewhere, and name the relevant special issue if applicable. Authors may also suggest preferred or non-preferred peer reviewers in the cover letter.
Reformat to Cancer Imaging using Livewrite PremiumWhat are the publication costs?
The current article processing charge is £2290.00 GBP / $2890.00 USD / €2490.00 EUR, subject to VAT or local taxes where applicable.
Reformat to Cancer Imaging using Livewrite PremiumResearch Topics
Radiomics and Machine Learning in Medical Imaging
MRI in cancer diagnosis
Medical Imaging Techniques and Applications
Lung Cancer Diagnosis and Treatment
Hepatocellular Carcinoma Treatment and Prognosis
Glioma Diagnosis and Treatment
Head and Neck Cancer Studies
Prostate Cancer Diagnosis and Treatment
Advanced X-ray and CT Imaging
Pancreatic and Hepatic Oncology Research
Advanced MRI Techniques and Applications
Prostate Cancer Treatment and Research
Medical Imaging and Pathology Studies
Renal cell carcinoma treatment
Sarcoma Diagnosis and Treatment
Radiopharmaceutical Chemistry and Applications
Breast Cancer Treatment Studies
Advanced Radiotherapy Techniques
Lung Cancer Treatments and Mutations
Esophageal Cancer Research and Treatment
Endometrial and Cervical Cancer Treatments
Ovarian cancer diagnosis and treatment
Cholangiocarcinoma and Gallbladder Cancer Studies
Colorectal Cancer Surgical Treatments
Thyroid Cancer Diagnosis and Treatment